Keep Dreaming
A new study shows just how few Americans have been infected with the deadly pathogen.
David Axe has covered war and politics for The Daily Beast, Vice, The Village Voice, The Washington Times and C-SPAN.
Send him tips: david.t.axe@gmail.com or tips@thedailybeast.com. You can also use our anonymous document submission system, SecureDrop. Click here to find out how.
Prepare for Impact
Critics say the writing is on the wall—even if they’re holding out hope for scientists to do the right thing.
‘Extremely Potent’
Scientists say a new antibody approach could both treat and help prevent COVID-19—even if it mutates. But will it arrive before a vaccine?
Thirst Trap?
The United Arab Emirates. Russia. China. Experts say there is plenty of reason to be skeptical.
‘CRIMINAL NEGLIGENCE’
“If we had the leadership we needed, I’m pretty certain we would have been under 100,000 fatalities—and probably under 50,000 if we had been aggressive from the beginning.”
SCIENTIFIC METHOD
The vaccine, in Phase 3 trials, was put on hold due to an unspecified adverse reaction in a patient—which means that the science-based vetting process is rigorous and it’s working.
Hope on Ice
From refrigeration woes to anti-vaxxer sentiment, rushing vaccine safety trials is far from the only way this could go bad.
Red Flag?
It’s either a testament to the immune system, or a terrifying sign of limited immunity.
Spending Spree
The tests are promising. But this kind of test has also been used to deflate COVID-19 case totals, critics say.
Plowing Ahead
The FDA move backing a treatment with only middling data to support it came just on the eve of the Republican National Convention—and despite reports of expert dissent.
